Literature DB >> 26546777

IL28B gene polymorphisms and Th1/Th2 cytokine levels might be associated with HTLV-associated arthropathy.

Keyla Santos Guedes de Sá1, Bárbara Brasil Santana1, Tuane Carolina de Souza Ferreira1, Rita Catarina Medeiros Sousa2, Cezar Augusto Muniz Caldas2, Vânia Nakauth Azevedo1, Rosimar Neris Martins Feitosa1, Luiz Fernando Almeida Machado1, Marluísa de Oliveira Guimarães Ishak1, Ricardo Ishak1, Antonio Carlos Rosário Vallinoto3.   

Abstract

The present study is the first investigation of the association between single nucleotide polymorphisms (SNPs - rs8099917, rs12979860 and rs8103142) of the IL28B gene and the development of human T-lymphotropic virus (HTLV)-associated arthropathy (HAA). Individuals with HAA exhibited low interleukin (IL) 6 (p<0.05) and high IL-10 (p<0.05) levels compared with asymptomatic patients. TNF-α/CD4(+) T cell count, TNF-α/CD8(+) T cell count and IFN-γ/proviral load positively correlated in asymptomatic patients. The allelic and genotypic frequencies did not differ between patients with HAA and asymptomatic patients. Seven haplotypes were detected in the investigated population, with haplotype CCT (p<0.05) being the most frequent among the HTLV-infected individuals, while haplotype TTG (p<0.05) was detected in the group with HAA only. Compared with asymptomatic patients, individuals with HAA and genotype TT (rs8099917) exhibited larger numbers of CD8(+) T cells (p<0.05) and higher proviral load levels (p<0.05). Those patients with HAA and genotypes CC (rs12979860) and TT (rs8103142) exhibited high TNF-β (p<0.05) and IFN-γ (p<0.05) levels. Those patients with HAA and genotype CT/TT (rs12979860) exhibited high IL-10 levels (p<0.05). These results suggest that haplotypes CCT and TTG might be associated with susceptibility to HTLV infection and progression to HAA, respectively. Genotype TT (rs8099917) might be a risk factor for elevation of the proviral load and CD8(+) T cell count. In addition, genotypes CC (rs12979860) and TT (rs8103142) seem to be associated with increased TNF-β and IFN-γ levels.
Copyright © 2015 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  HTLV-associated arthropathy; IL-28B; rs12979860; rs8099917; rs8103142

Mesh:

Substances:

Year:  2015        PMID: 26546777     DOI: 10.1016/j.cyto.2015.11.004

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  6 in total

1.  IL-28B Genetic Variants Determine the Extent of Monocyte-Induced Activation of NK Cells in Hepatitis C.

Authors:  Benjamin Krämer; Claudia Finnemann; Beatriz Sastre; Philipp Lutz; Andreas Glässner; Franziska Wolter; Felix Goeser; Pavlos Kokordelis; Dominik Kaczmarek; Hans-Dieter Nischalke; Christian P Strassburg; Ulrich Spengler; Jacob Nattermann
Journal:  PLoS One       Date:  2016-09-01       Impact factor: 3.240

Review 2.  Interferon Lambda: Modulating Immunity in Infectious Diseases.

Authors:  Mohammedyaseen Syedbasha; Adrian Egli
Journal:  Front Immunol       Date:  2017-02-28       Impact factor: 7.561

Review 3.  Gene-disease association with human IFNL locus polymorphisms extends beyond hepatitis C virus infections.

Authors:  S Chinnaswamy
Journal:  Genes Immun       Date:  2016-06-09       Impact factor: 2.676

4.  Family Aggregation of HTLV-1 Infection Associated with FAS -670A/G Polymorphism: A Case Report.

Authors:  Antonio C R Vallinoto; Bárbara B Santana; Maria A F Queiroz; Andrea N M R da Silva; Izaura M V Cayres-Vallinoto; Carlos A da Costa; Maisa S de Sousa; Ricardo Ishak
Journal:  Front Microbiol       Date:  2018-01-15       Impact factor: 5.640

5.  IFNG +874A/T Polymorphism Among Asymptomatic HTLV-1-Infected Individuals Is Potentially Related to a Worse Prognosis.

Authors:  Maria A F Queiroz; Vânia N Azevedo; Ednelza da S G Amoras; Tuane C F Moura; Marluísa de O Guimarães Ishak; Ricardo Ishak; Antonio C R Vallinoto; Rosimar N Martins Feitosa
Journal:  Front Microbiol       Date:  2018-05-18       Impact factor: 5.640

Review 6.  Influence of Immunogenetic Biomarkers in the Clinical Outcome of HTLV-1 Infected Persons.

Authors:  Antonio Carlos Rosário Vallinoto; Izaura Cayres-Vallinoto; Maria Alice Freitas Queiroz; Marluísa de Oliveira Guimarães Ishak; Ricardo Ishak
Journal:  Viruses       Date:  2019-10-23       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.